Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 45 for “"CHEK2"”.
-
Functional Evaluation Of Chek2 Single Nucleotide Variants In Hereditary Cancer Predisposition
… plan.The cell cycle checkpoint kinase 2 (CHEK2) is a tumor suppressor gene coding for a protein kinase with a role in the cell cycle and DNA repair pathways. Mutations within CHEK2 are associated with an increased risk of developing breast, colorectal, prostate and several other types of …
-
Comprehensively Testing the Function of Missense Variation in the STK11 CHEK2 Tumour Suppressors
… tumour suppressor proteins, STK11/LKB1 and CHEK2, approximately 87% and 95% of missense variants in ClinVar are classified as VUS respectively. This thesis details DMS experiments that tested protein function for almost all possible coding (covering approximately 90% of single-nucleotide …
-
Medical Decision Making among Individuals with a Variant of Uncertain Significance in a Hereditary Cancer Gene and those with a CHEK2 Pathogenic Variant
… national guidelines, women with a BRCA VUS or CHEK2 pathogenic variant are choosing to have risk-reducing surgeries such as bilateral mastectomies which are not aligned with their level of cancer risk based on genetic test results alone. Semi-structured telephone interviews were conducted with …
-
Mutationsanalyse der Zellzyklus-Kontrollpunktkinase Chk2 in humanen Tumorzelllinien
… oder Zelltod durch Apoptose. Eine Bedeutung von Chek2 (das Chk2-kodierende Gen) als tumorkritisches Gen wurde für viele Gewebearten gezeigt. Fragestellung: In dieser Arbeit wurden humane Tumorzelllinien auf Mutationen in den kodierenden Abschnitten des Chek2-Gens untersucht. Das Ziel war zum …
-
Alteración de los patrones de splicing en genes de susceptibilidad a cáncer de mama: análisis funcional mediante minigenes híbridos.
… with breast cancer: BRCA1, BRCA2, PALB2, CHEK2, ATM, BARD1, RAD51C and RAD51D. Screening of these genes using high-throughput sequencing has allowed the detection of thousands of variants, many of them classified as variants of unknown significance (VUS). Interestingly, splicing …
-
Agresyvios eigos prostatos vėžio nustatymas taikant skysčių biopsiją /
… response (DDR) pathway genes (ATM, BRCA1, BRCA2, CHEK2, and NBN) in blood and/or urine samples and to assess the impact of these mutations on the clinical course of PCa in the advanced and localized setting. DDR pathway gene mutations were prospectively evaluated in leukocyte and urine DNA from …
-
The impact of germline genotype on breast cancer tumour phenotype and outcome
… between gene carriers (BRCA1+, BRCA2+, PALB2+, CHEK2+, ATM+ and TP53+) and non-carriers. Kaplan Meier analysis was used to estimate differences between carriers and no-carriers for Overall Survival (OS) and Distant Disease-Free Survival (DDFS). A further sample with tumour sequence data and a …
-
Ταυτοποίηση νέων αλληλόμορφων σε γονίδια προδιάθεσης για τον καρκίνο του μαστού και των ωοθηκών
… carriers were originated from Crete Island.CHEK2 is a well-studied breast cancer susceptibility gene, beyond BRCA1 and BRCA2 genes. In the present study, the medium penetrance gene CHEK2 was analyzed in order to characterize the mutation spectrum in Greek population. Initially, 2,408 women …
-
GENOME STABILITY DURING NEURODEVELOPMENT: THE IMPORTANCE OF THE STRUCTURAL MAINTENANCE OF CHROMOSOMES COMPLEX, SMC5/6
… layer neurons. SMC5/6 knockout triggers a CHEK2-p53 DNA damage response, as concurrent deletion of the Trp53 tumor suppressor or Chek2 DNA damage checkpoint kinase alleviated Smc5 cKO neurodevelopmental deficiencies. In Chapter III we investigated the roles of SMC5/6 in mouse behavior and …
-
Caracterización histológica y molecular de una serie de casos de melanoma uveal primario con correlación clínica y pronóstica
… o de cuerpo ciliar, mutación en BAP1, CHEK2, TSC2, DICER o IDO1 tienen más riesgo de producir metástasis en cualquier momento del seguimiento. Conclusiones: BAP1 es el biomarcador más sólido de mal pronóstico en MU y sus mutaciones pueden detectarse mediante NGS. SF3B1 se asocia con el …
-
Λειτουργική αξιολόγηση γνωστών παραλλαγών αγνώστου κλινικής σημασίας κια χαρακτηρισμός νέων μεταλλάξεων σε γονίδια που εμπλέκονται στον κληρονομικό καρκίνο μαστού - ωοθηκών
… genetic variants on the carriers’ phenotypes.CHEK2 gene mutations have been associated with cancer predisposition, mainly of the breast, colon, prostate, gastric and thyroid. The use of new molecular methods of massive parallel sequencing in cancer patient genetic testing has revealed a …
-
Ανίχνευση νέων αλληλομόρφων σε γονίδια που προδιαθέτουν για τον κληρονομικό καρκίνο
… and BRCA2 genes and a maximum of 2.5% in ATM, CHEK2, PALB2, PTEN, TP53, etc. The corresponding percentages for epithelial ovarian cancer range between 20-30% for BRCA1 and BRCA2 and 6-15% for the rest of panel genes. A targeted clinical surveillance and additional preventive measures could be …
-
Regulación del splicing alternativo y aberrante en genes de reparación del ADN y susceptibilidad hereditaria a cáncer de mama/ovario
… susceptibility genes: ATM, BARD1, BRCA1, BRCA2, CHEK2, PALB2, RAD51C, and RAD51D. The use of high-throughput sequencing techniques to identify deleterious variants in these genes has markedly increased the detection of variants of uncertain clinical significance (VUS). Many of these variants can …
-
Breast cancer in young women. Aspects of heredity and contralateral disease.
… (19%), BRCA2 (7%), and other genes, i.e., TP53, CHEK2, and PALB2 (4.5%). Compared with other groups, women with pathogenic variants in BRCA1 were more likely to be diagnosed with high grade, estrogen receptor-, progesterone receptor-, and triple-negative tumors. We also noted that even though all …
-
Ταυτοποίηση νέων αλληλομόρφων που σχετίζονται με προδιάθεση για καρκίνο μαστού-ωοθηκών
… cancer, while in the present work BRCA1, BRCA2, CHEK2, PALB2 and RAD51C genes were analyzed in patients with early onset of cancer (17-40 years) or/and more than 3 cases of breast/ovarian cancer in the same family. The goal of this study was the identification of new pathogenic mutations in these …
-
Κοινά μοριακά μονοπάτια παθογένεσης καρκίνου μαστού και αναπαραγωγικού συστήματος θήλεος
… συνδρόμων είναι τα BRCA1, BRCA2, p53, ΡΤΕΝ, CHEK2, CDH1, MSH2/6, ATM, STK11, RAD50, BRIP1 και PALB2. Οι μηχανισμοί καρκινογένεσης του μαστού λόγω της πολυπλοκότητας τους δεν είναι πλήρως αποσαφηνισμένοι. Στην ογκογένεση του μαστού εμπλέκονται πολλά σηματοδοτικά μονοπάτια, τα οποία υπό …
-
CONDITIONAL DEPLETION OF SMC5 LEADS TO MICROCEPHALY, MEDIATED BY THE ATM-CHK2-TP53 PATHWAY
… Smc5 cKO, Smc5 Trp53 double KO (dKO), and Smc5 Chek2 dKO mouse brain sections using cortical layer-specific markers, NPCs markers, as well as DNA replication and damage response markers. We have successfully modeled the neurodevelopmental defects observed when Smc5/6 function is perturbed in …
-
The etiology, diagnosis and treatment of breast cancer in males /
… black ethnecity, genetic mutations in the CHEK2, PALB2, CYP17, BRCA1, and BRCA2 genes, alterations of the estrogen to androgen ratio, and primary testicular conditions. Male breast cancer typically presents as a unilateral, painless, retroareolar mass with possible additional signs and …
-
Characterizing the combined role of rare and common variants for prostate cancer risk
… PCa risk genes (BIK, FAM111A, HOXB13, BRCA2, CHEK2 and ATM). We found evidence of an additive interaction between the PRS and rare variant carrier status, with carriers defined as those with 1 pathogenic coding variant in any of the 6 genes mentioned above. We observe significantly higher risk …
Page 1 of 3